S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
NASDAQ:CRVO

CervoMed (CRVO) Stock Price, News & Analysis

$25.19
-0.01 (-0.04%)
(As of 04/12/2024 ET)
Today's Range
$22.77
$25.20
50-Day Range
$8.39
$25.93
52-Week Range
$4.14
$26.38
Volume
24,304 shs
Average Volume
24,274 shs
Market Capitalization
$155.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.50

CervoMed MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
128.3% Upside
$57.50 Price Target
Short Interest
Healthy
0.60% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.87mentions of CervoMed in the last 14 days
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($1.13) to ($1.62) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.54 out of 5 stars

Medical Sector

718th out of 923 stocks

Pharmaceutical Preparations Industry

337th out of 430 stocks

CRVO stock logo

About CervoMed Stock (NASDAQ:CRVO)

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

CRVO Stock Price History

CRVO Stock News Headlines

Options trading has suddenly become more reliable.
When it hits at a stunning 96% win rate... Options trading has suddenly become more reliable.
Options trading has suddenly become more reliable.
When it hits at a stunning 96% win rate... Options trading has suddenly become more reliable.
CervoMed secures $50 million in private placement
See More Headlines
Receive CRVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CervoMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
4/13/2024
Next Earnings (Estimated)
7/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CRVO
Previous Symbol
NASDAQ:CRVO
Employees
4
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$57.50
High Stock Price Target
$65.00
Low Stock Price Target
$50.00
Potential Upside/Downside
+128.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-2,170,000.00
Pretax Margin
-30.40%

Debt

Sales & Book Value

Annual Sales
$7.14 million
Book Value
$1.30 per share

Miscellaneous

Free Float
6,047,000
Market Cap
$155.42 million
Optionable
Not Optionable
Beta
1.50
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. John J. Alam M.D. (Age 62)
    Co-Founder, CEO, President & Director
  • Dr. Sylvie L. Gregoire Pharm.D. (Age 63)
    Co-Founder & Director
  • Dr. John William Tanner Ph.D. (Age 65)
    Chief Financial Officer
  • Dr. Robert J. Cobuzzi Jr. (Age 59)
    Ph.D., COO & Director
  • Mr. William Robert Elder J.D. (Age 41)
    General Counsel & Corporate Secretary
  • Ms. Kelly Blackburn M.H.A. (Age 60)
    Senior Vice President of Clinical Development

CRVO Stock Analysis - Frequently Asked Questions

Should I buy or sell CervoMed stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CervoMed in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRVO shares.
View CRVO analyst ratings
or view top-rated stocks.

What is CervoMed's stock price target for 2024?

2 Wall Street analysts have issued 12 month target prices for CervoMed's stock. Their CRVO share price targets range from $50.00 to $65.00. On average, they expect the company's share price to reach $57.50 in the next year. This suggests a possible upside of 128.3% from the stock's current price.
View analysts price targets for CRVO
or view top-rated stocks among Wall Street analysts.

How have CRVO shares performed in 2024?

CervoMed's stock was trading at $7.63 at the beginning of the year. Since then, CRVO stock has increased by 230.1% and is now trading at $25.19.
View the best growth stocks for 2024 here
.

Are investors shorting CervoMed?

CervoMed saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 20,600 shares, an increase of 11.4% from the March 15th total of 18,500 shares. Based on an average trading volume of 27,600 shares, the short-interest ratio is currently 0.7 days. Currently, 0.6% of the shares of the stock are short sold.
View CervoMed's Short Interest
.

When is CervoMed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, July 5th 2024.
View our CRVO earnings forecast
.

How were CervoMed's earnings last quarter?

CervoMed Inc. (NASDAQ:CRVO) released its quarterly earnings results on Monday, November, 13th. The company reported ($0.70) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.95) by $0.25. The business earned $1.53 million during the quarter.

How do I buy shares of CervoMed?

Shares of CRVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRVO) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners